These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 17722021

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Percutaneous devices for stroke prevention.
    Bayard YL, Ostermayer SH, Hein R, Skowasch M, Büscheck F, Baranowski A, Heinisch C, Sievert H.
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [Abstract] [Full Text] [Related]

  • 43. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
    Majunke N, Baranowski A, Zimmermann W, Heinisch C, Wilson N, Robertson G, Wunderlich N, Sievert H.
    Catheter Cardiovasc Interv; 2009 Feb 15; 73(3):376-82. PubMed ID: 19085919
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Migraine headache relief after percutaneous transcatheter closure of interatrial communications.
    Dubiel M, Bruch L, Schmehl I, Liebner M, Winkelmann A, Stretz A, Grad MO, Kleber FX.
    J Interv Cardiol; 2008 Feb 15; 21(1):32-7. PubMed ID: 18093099
    [Abstract] [Full Text] [Related]

  • 46. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M, Bruch L, Liebner M, Schmehl I, Winkelmann A, Rux S, Sonntag S, Wulff H, Grad MO, Kleber FX.
    J Interv Cardiol; 2007 Aug 15; 20(4):275-81. PubMed ID: 17680857
    [Abstract] [Full Text] [Related]

  • 47. Transcatheter closure of patent foramen ovale in older adults.
    Kiblawi FM, Sommer RJ, Levchuck SG.
    Catheter Cardiovasc Interv; 2006 Jul 15; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
    [Abstract] [Full Text] [Related]

  • 48. [Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences].
    Kaya MG, Ozdoğru I, Baykan A, Doğan A, Inanç T, Doğdu O, Uzüm K, Narin N, Topsakal R, Ergin A, Oğuzhan A, Eryol NK.
    Turk Kardiyol Dern Ars; 2008 Jul 15; 36(5):287-93. PubMed ID: 18984979
    [Abstract] [Full Text] [Related]

  • 49. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
    Sievert H, Fischer E, Heinisch C, Majunke N, Roemer A, Wunderlich N.
    Circulation; 2007 Oct 09; 116(15):1701-6. PubMed ID: 17893276
    [Abstract] [Full Text] [Related]

  • 50. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler.
    Anzola GP, Morandi E, Casilli F, Onorato E.
    Stroke; 2004 Sep 09; 35(9):2140-4. PubMed ID: 15284445
    [Abstract] [Full Text] [Related]

  • 51. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H.
    Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):889-95. PubMed ID: 19626689
    [Abstract] [Full Text] [Related]

  • 52. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients.
    Sievert H, Ruygrok P, Salkeld M, Baumgartner H, Meier B, Windecker S, Juliard JM, Aubry P, Tiefenbacher C, Krumsdorf U, Vermeersch P, Ewert P, Piéchaud JF.
    Catheter Cardiovasc Interv; 2009 Feb 15; 73(3):368-73. PubMed ID: 19133667
    [Abstract] [Full Text] [Related]

  • 53. Patent foramen ovale and migraine.
    Post MC, Luermans JG, Plokker HW, Budts W.
    Catheter Cardiovasc Interv; 2007 Jan 15; 69(1):9-14. PubMed ID: 17143907
    [Abstract] [Full Text] [Related]

  • 54. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C, Khandelwal A, Timmermanns I, Schräder R.
    Am J Cardiol; 2008 Oct 01; 102(7):902-6. PubMed ID: 18805119
    [Abstract] [Full Text] [Related]

  • 55. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
    Earing MG, Cabalka AK, Seward JB, Bruce CJ, Reeder GS, Hagler DJ.
    Mayo Clin Proc; 2004 Jan 01; 79(1):24-34. PubMed ID: 14708945
    [Abstract] [Full Text] [Related]

  • 56. Sustained long-term benefit of patent foramen ovale closure on migraine.
    Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Teruzzi G, Grancini L, Gatto P, Bartorelli AL.
    Catheter Cardiovasc Interv; 2011 Mar 01; 77(4):570-4. PubMed ID: 21351231
    [Abstract] [Full Text] [Related]

  • 57. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
    Rigatelli G, Giordan M, Braggion G, Aggio S, Chinaglia M, Zattoni L, Milan T, Cardaioli P.
    Cardiovasc Revasc Med; 2007 Mar 01; 8(4):248-50. PubMed ID: 18053946
    [Abstract] [Full Text] [Related]

  • 58. May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression?
    Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Nanjundappa A, Mandapaka S, Chinaglia M.
    Cardiovasc Revasc Med; 2011 Mar 01; 12(4):217-9. PubMed ID: 21195033
    [Abstract] [Full Text] [Related]

  • 59. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
    Van Den Branden BJ, Post MC, Plokker HW, Ten Berg JM, Suttorp MJ.
    J Interv Cardiol; 2011 Jun 01; 24(3):264-70. PubMed ID: 21198853
    [Abstract] [Full Text] [Related]

  • 60. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H, Ungan I, Tureli D, Demir B, Pirhan O, Bayrak HI, Caglar IM, Karakaya O, Inci E.
    J Invasive Cardiol; 2013 Oct 01; 25(10):519-24. PubMed ID: 24088426
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.